Michael B Plewe
About Michael B Plewe
Michael Plewe: Senior Vice President - Medicinal Chemistry
Michael Plewe holds the position of Senior Vice President in the field of Medicinal Chemistry. In this role, he is responsible for overseeing research efforts, developing new chemical entities, and guiding the strategic direction of pharmaceutical projects. His leadership in medicinal chemistry contributes significantly to the organization's objectives in drug discovery and development.
Michael Plewe's Conference Presentations on Discovery of Novel E3 Ligands
Michael Plewe has actively presented on the 'Discovery of Novel E3 Ligands for Targeted Protein Degradation'. His presentations at various international conferences highlight his contributions in this specialized domain of medicinal chemistry. Through these engagements, Plewe shares his research findings and insights, driving forward the discourse on targeted protein degradation.
Michael Plewe at the 2nd Targeted Protein Degradation Conference in Japan
In July 2023, Michael Plewe spoke at the 2nd Targeted Protein Degradation Conference held in Japan. During this event, he discussed his work on novel E3 ligands, sharing valuable information and advancements with peers and industry leaders. His participation underscores his prominence in the field and his commitment to advancing targeted protein degradation technologies.
Michael Plewe at the SACHS 23rd Annual Biotech in Europe Forum
Michael Plewe participated in a panel discussion on 'Advances in Immuno-Oncology' at the SACHS 23rd Annual Biotech in Europe Forum in September 2023. His contributions to the panel provided insights into the latest trends and advancements in the immuno-oncology sector, reflecting his involvement in cutting-edge biotech research and his role in fostering innovation within the industry.